Inhibitors of the Heat Shock Response: Biology and Pharmacology

Overview

Journal FEBS Lett

Specialty Biochemistry

Date 2007 Jun 15

PMID 17559840

Citations 134

Authors

Marissa V Powers

Paul Workman

Affiliations

Soon will be listed here.

Abstract

A number of human diseases can be linked to aberrations in protein folding which cause an imbalance in protein homeostasis. Molecular chaperones, including heat shock proteins, act to assist protein folding, stability and activity in the cell. Attention has begun to focus on modulating the expression and/or activity of this group of proteins for the treatment of a wide variety of human diseases. This review will describe the progress made to date in developing pharmacological modulators of the heat shock response, including both agents which affect the entire heat shock response and those that specifically target the HSP70 and HSP90 chaperone families.

Citing Articles

A novel nanodrug for the sensitization of photothermal chemotherapy for breast cancer .

Kong J, Zhou F, Shi L, Wei Y, Wu C RSC Adv. 2024; 14(30):21292-21299.

PMID: 38974230 PMC: 11225340. DOI: 10.1039/d4ra01611d.

Heat shock factor 1 inhibition enhances the effects of modulated electro hyperthermia in a triple negative breast cancer mouse model.

Viana P, Schvarcz C, Danics L, Besztercei B, Aloss K, Bokhari S Sci Rep. 2024; 14(1):8241.

PMID: 38589452 PMC: 11002009. DOI: 10.1038/s41598-024-57659-x.

Phase Ib study of HSP90 inhibitor, onalespib (AT13387), in combination with paclitaxel in patients with advanced triple-negative breast cancer.

Williams N, Quiroga D, Johnson C, Brufsky A, Chambers M, Bhattacharya S Ther Adv Med Oncol. 2023; 15:17588359231217976.

PMID: 38152697 PMC: 10752118. DOI: 10.1177/17588359231217976.

Binding Mechanism of Inhibitors to Heat Shock Protein 90 Investigated by Multiple Independent Molecular Dynamics Simulations and Prediction of Binding Free Energy.

Yang F, Wang Y, Yan D, Liu Z, Wei B, Chen J Molecules. 2023; 28(12).

PMID: 37375347 PMC: 10304427. DOI: 10.3390/molecules28124792.

Structural Basis of Parasitic HSP90 ATPase Inhibition by Small Molecules.

Tassone G, Mazzorana M, Pozzi C Pharmaceuticals (Basel). 2022; 15(11).

PMID: 36355513 PMC: 9692773. DOI: 10.3390/ph15111341.